Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AN2 Therapeutics, Inc. | 10,362 | reported | 19 Mar 2026 | tx 16+235,366−44,769 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 10,665 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 10,665 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 10,362 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 23,742 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 23,742 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 10,362 | — | deriv |
| 20 Feb 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 20,400 | 0.00 USD | deriv |
| 12 Jan 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 11,560 | 0.00 USD | |
| 10 Oct 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 10,367 | 0.00 USD | |
| 10 Jul 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 11,875 | 0.00 USD | |
| 22 May 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 19,111 | 0.00 USD | deriv |
| 10 Apr 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 9,705 | 0.00 USD | |
| 19 Dec 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 8,972 | 0.00 USD | |
| 19 Jun 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 64,503 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | AN2 Therapeutics, Inc. | 23,742 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | AN2 Therapeutics, Inc. | 10,362 | 0.00 USD | deriv |